ArticleMethods in molecular biology (Clifton, N.J.)2026
Protein Targeting Signals and Strategies for Pichia pastoris.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Besides the simplicity of genetic modification and convenient low-effort cultivation, Pichia pastoris (today mostly Komagataella phaffii species are used for biotechnology) comes with another great advantage: simple targeting of recombinant proteins to different compartments of the host cell. Indeed, the most prominent pathway for recombinant proteins is the secretory pathway, whereby the protein is guided through the endoplasmic reticulum (ER) and Golgi apparatus, resulting in secretion at the cell surface. Secreted proteins can be separated from the cells, forgoing expensive cell disruption and purification processes. However, there are further localization sites for recombinant proteins (e.g., mitochondria, nucleus, peroxisomes, vacuole, cytoplasmic membrane, cell wall, etc.), technologically relevant.
Indexed as
Identifiers
41028466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.